Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Betteridge

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
Cardiovascular Drugs and Therapy|June 1, 1989
Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapyM D Feher, D J Betteridge
Postgraduate Medical Journal|April 1, 1986
Short PR intervals and tachyarrhythmias in Fabry's diseaseJ Efthimiou, J McLelland, D J Betteridge
British Medical Journal|July 9, 1977
Diagnosing familial hypercholesterolaemia in childhoodD J Betteridge, D Galton, M Giggins
Postgraduate Medical Journal|December 1, 1996
Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemiaD J Betteridge, C G O'Bryan-Tear
Current Opinion in Lipidology|November 22, 2000
Status report of lipid-lowering trials in diabetesD J Betteridge, H Colhoun, J Armitage
European Journal of Clinical Investigation|August 1, 1988
Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndromeA P Wilson, J Efthimiou, D J Betteridge
Journal of Cardiovascular Risk|September 12, 2001
PPARS, insulin resistance and type 2 diabetesF Kaplan, K Al-Majali, D J Betteridge
European Journal of Clinical Investigation|October 1, 1979
Mechanism of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein in human lymphocytesW Krone, D J Betteridge, D J Galton
Biochimica Et Biophysica Acta|August 30, 1979
Regulation of sterol synthesis in human lymphocytes: evidence for post-transcriptional control by low density lipoproteinW Krone, D J Betteridge, D J Galton
Atherosclerosis|June 8, 2001
Measures of oxidative stress in heterozygous familial hypercholesterolaemiaJ Nourooz-Zadeh, C C Smith, D J Betteridge
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Cardiovascular Drugs and Therapy|June 1, 1989
Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapyM D Feher, D J Betteridge
Postgraduate Medical Journal|April 1, 1986
Short PR intervals and tachyarrhythmias in Fabry's diseaseJ Efthimiou, J McLelland, D J Betteridge
British Medical Journal|July 9, 1977
Diagnosing familial hypercholesterolaemia in childhoodD J Betteridge, D Galton, M Giggins
Postgraduate Medical Journal|December 1, 1996
Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemiaD J Betteridge, C G O'Bryan-Tear
Current Opinion in Lipidology|November 22, 2000
Status report of lipid-lowering trials in diabetesD J Betteridge, H Colhoun, J Armitage
European Journal of Clinical Investigation|August 1, 1988
Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndromeA P Wilson, J Efthimiou, D J Betteridge
Journal of Cardiovascular Risk|September 12, 2001
PPARS, insulin resistance and type 2 diabetesF Kaplan, K Al-Majali, D J Betteridge
European Journal of Clinical Investigation|October 1, 1979
Mechanism of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein in human lymphocytesW Krone, D J Betteridge, D J Galton
Biochimica Et Biophysica Acta|August 30, 1979
Regulation of sterol synthesis in human lymphocytes: evidence for post-transcriptional control by low density lipoproteinW Krone, D J Betteridge, D J Galton
Atherosclerosis|June 8, 2001
Measures of oxidative stress in heterozygous familial hypercholesterolaemiaJ Nourooz-Zadeh, C C Smith, D J Betteridge
Pageof 16